Skip to content

DM1 Heart Registry - DM1 Respiratory Registry

Cardiac and Respiratory Prognostic Factors in Patients With Myotonic Dystrophy Type 1

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01136330
Acronym
DM1-Heart-R
Enrollment
914
Registered
2010-06-03
Start date
2010-05-31
Completion date
2011-09-30
Last updated
2012-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myotonic Dystrophy

Keywords

Myotonic dystrophy, Prognosis, Sudden death, Respiratory failure

Brief summary

Myotonic dystrophy type 1 (DM1) is the most frequent neuromuscular disease in adults. DM1 patients have an impaired prognosis (mean age of death \<60 years) due to cardiac and respiratory complications. Our primary objective was to identify cardiac and respiratory prognostic factors in DM1.

Detailed description

1. Patients with genetically proven DM1 who were admitted in Pitié Salpêtrière Hospital from 2000 and 2010 will be identified. These patients systematically underwent neurological, cardiac and respiratory investigations. 2. Baseline medical and genetic information will be entered in a dedicated database, including cardiac and respiratory investigations. 3. The occurence of severe cardiac and respiratory adverse events will also be collected. 4. Statistical analysis will be performed to look for correlations between baseline patient characteristics and cardiac or respiratory adverse events during follow up.

Interventions

None listed

Sponsors

Institut de Myologie, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* DM1 mutation (\>50 CTG repeats) * Age \> 18 years

Exclusion criteria

* Patient refusal

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026